Semaglutide's CVD indication could cost US Medicare $145bn extra a year. Mahase E. BMJ 2024;386:q1878.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mahase E. Semaglutide's CVD indication could cost US Medicare $145bn extra a year. BMJ 2024;386:q1878.
PMID: 39197936